Anixa Biosciences, Inc.
ANIX
$3.38
-$0.17-4.79%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.69% | -18.85% | 17.48% | -5.07% | 13.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.38% | -6.18% | 3.67% | 26.30% | 25.16% |
| Operating Income | 13.38% | 6.18% | -3.67% | -26.30% | -35.43% |
| Income Before Tax | 11.54% | 2.34% | -7.06% | -30.10% | -37.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.54% | 2.34% | -7.06% | -30.10% | -37.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.90% | -17.14% | -3.23% | 2.70% | 115.79% |
| Net Income | 11.12% | 2.18% | -7.17% | -30.51% | -37.19% |
| EBIT | 13.38% | 6.18% | -3.67% | -26.30% | -35.43% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 11.99% | 4.44% | -3.58% | -26.02% | -32.97% |
| Normalized Basic EPS | 11.64% | 4.35% | -3.54% | -26.49% | -32.61% |
| EPS Diluted | 11.99% | 4.44% | -3.58% | -26.02% | -32.97% |
| Normalized Diluted EPS | 11.64% | 4.35% | -3.54% | -26.49% | -32.61% |
| Average Basic Shares Outstanding | 0.90% | 2.39% | 3.48% | 3.49% | 3.18% |
| Average Diluted Shares Outstanding | 0.90% | 2.39% | 3.48% | 3.49% | 3.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |